Tadalafil Alpha blockers

Flypersensitivity to any component of the tablet administration with nitrates (either regularly and/or intermittently) and nitric oxide donors because of the potentiation of hypotension (see Drug Interactions) coadministration with alpha-blockers (vardenafil only) coadministration with alpha-blockers other than 0.4 mg/day tamsulosin (tadalafil only). 

Kloner RA, Jackson G, EmmickJT, et al, Interaction between phosphodiesterase 5 inhibitor, tadalafil, and two alpha blockers, doxazosin and tamsulosin in healthy normotensive men. J Urol 2004 172 1935-1940. 

The UK manufacturer of tadalafll says that the concurrent use of alpha blockers and tadalafll is not recommended as it may lead to symptomatic hypotension in some patients. Conversely, the US manufacturer recommends that patients should be stable on their alpha blocker before tadalafll is used, and that tadalafll should be initiated at the lowest recommended dose. When starting an alpha blocker in a patient taking the optimum dose of tadalafil, the alpha blocker should be initiated at the lowest possible dose. ... 

No clinically relevant interactions appear to occur between sildenafil, tadalafil or vardenafil and most antihypertensive drugs. The exceptions may be diltiazem and verapamil. The potentially serious interactions of sildenafil, tadalafil and vardenafil with the alpha blockers and nitrates are discussed elsewhere. See Phosphodiesterase type-5 inhibitors + Alpha blockers , p.l268 and Phosphodiesterase type-5 inhibitors -I- Nitrates , p.l272. 

---